Health Gorilla vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 52)
Health Gorilla logo

Health Gorilla

ChallengerHealthcare

Health Information Network & Clinical Data Exchange

Health Gorilla is a TEFCA-designated QHIN enabling AI-ready clinical data exchange; raised $80M total ($50M Series C led by SignalFire); named TIME Top HealthTech Company 2025; supports FHIR-based nationwide data sharing.

AI VisibilityBeta
Overall Score
C52
Category Rank
#299 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
54
Perplexity
49
Gemini
54

About

Health Gorilla is a health information network and API company that enables secure, nationwide clinical data exchange across payers, providers, EHR vendors, digital health companies, and laboratories. Founded in 2014 by Steve Yaskin in Los Angeles, California, Health Gorilla is designated as a Qualified Health Information Network (QHIN) under the Trusted Exchange Framework and Common Agreement (TEFCA) — the federal framework established by ONC to create a nationwide interoperability infrastructure for health data. This regulatory designation allows Health Gorilla to serve as a trusted intermediary for clinical data exchange across the US healthcare ecosystem, connecting disparate systems through standardized FHIR-based APIs.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

52
Overall Score
93
#299
Category Rank
#1
80
AI Consensus
80
stable
Trend
stable
54
ChatGPT
94
49
Perplexity
89
54
Gemini
94
48
Claude
92
55
Grok
98

Key Details

Category
Health Information Network & Clinical Data Exchange
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.